Cybin announces embark open access, the first free online course providing facilitator training for psychedelic therapy

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced the launch of embark open access (“embark oa”), a free online foundational training course for psychedelic facilitation.
CYBN Ratings Summary
CYBN Quant Ranking